Harvard Bioscience (HBIO) Net Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 81,515.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 420.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1,490.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 704.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -296.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -1,174.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -1,392.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 153.00 |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -1,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,852.00 |
| Dec 31, 2025 | -601.00 |
| Sep 30, 2025 | 667.00 |
| Jun 30, 2025 | -1,951.00 |
| Mar 31, 2025 | -20,694.00 |
| Dec 31, 2024 | -198.00 |
| Sep 30, 2024 | -2,123.00 |
| Jun 30, 2024 | -1,119.00 |
| Mar 31, 2024 | -1,667.00 |
| Dec 31, 2023 | 63.00 |
| Sep 30, 2023 | -25.00 |
| Jun 30, 2023 | 338.00 |
| Mar 31, 2023 | 2,102.00 |
| Dec 31, 2022 | -764.00 |
| Dec 31, 2021 | 475.00 |
| Jun 30, 2021 | -159.00 |
| Mar 31, 2021 | -915.00 |
| Dec 31, 2020 | -695.00 |
| Sep 30, 2020 | -586.00 |
| Jun 30, 2020 | -803.00 |